Window trial

JRCT ID: jRCTs051190006

Registered date:16/04/2019

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Solid tumor
• Date of first enrollment: 24/09/2015
• Target sample size: 200
• Study type: Interventional
• Intervention(s): Administration of itraconazole for 2~4 weeks

Outcome(s)

• Primary Outcome: Ki-67 index, serological and/or radiological response

Secondary Outcome

Symptom control ratio, Response rate
Adverse events
Biomarker using tissue and blood
Identification of new target

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

Patients who have window period before standard treatment
And who have no standard treatment

• Exclude criteria: Patients who have drugs which interferes CYP3A

Related Information

• Primary Sponsor: Tsubamoto Hiroshi
• Secondary ID(s): UMIN000018388